Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,730Revenue $M3,324Net Margin (%)8.6Altman Z-Score3.5
Enterprise Value $M13,358EPS $3.8Operating Margin %24.1Piotroski F-Score6
P/E(ttm)46.9Beneish M-Score-2.6Pre-tax Margin (%)13.4Higher ROA y-yN
Price/Book7.310-y EBITDA Growth Rate %11.2Quick Ratio1.8Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %8.5Current Ratio2.3Lower Leverage y-yY
Price/Free Cash Flow25.5y-y EBITDA Growth Rate %-52.8ROA % (ttm)5.7Higher Current Ratio y-yN
Dividend Yield %0.5PEG5.4ROE % (ttm)15.7Less Shares Outstanding y-yY
Payout Ratio %23.0Shares Outstanding M74.3ROIC % (ttm)29.7Gross Margin Increase y-yY

Gurus Latest Trades with BCR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRDonald Yacktman 2015-03-31 Reduce-0.79%$164.52 - $178.59
($171.43)
$ 171.460%Reduce 25.34%3,326,670
BCRYacktman Fund 2015-03-31 Reduce-0.75%$164.52 - $178.59
($171.43)
$ 171.460%Reduce 25.10%1,570,000
BCRYacktman Focused Fund 2015-03-31 Reduce-0.71%$164.52 - $178.59
($171.43)
$ 171.460%Reduce 24.41%1,220,000
BCRJoel Greenblatt 2015-03-31 Add0.04%$164.52 - $178.59
($171.43)
$ 171.460%Add 213.81%44,492
BCRYacktman Fund 2014-12-31 Reduce-1.42%$144.77 - $172.68
($161.89)
$ 171.466%Reduce 35.51%2,096,000
BCRDonald Yacktman 2014-12-31 Reduce-1.17%$144.77 - $172.68
($161.89)
$ 171.466%Reduce 30.85%4,455,796
BCRYacktman Focused Fund 2014-12-31 Reduce-0.82%$144.77 - $172.68
($161.89)
$ 171.466%Reduce 24.93%1,614,000
BCRRobert Olstein 2014-12-31 Sold Out -0.63%$144.77 - $172.68
($161.89)
$ 171.466%Sold Out0
BCRJoel Greenblatt 2014-12-31 Reduce-0.31%$144.77 - $172.68
($162.11)
$ 171.466%Reduce 93.82%14,178
BCRVanguard Health Care Fund 2014-12-31 Reduce-0.05%$144.77 - $172.68
($161.99)
$ 171.466%Reduce 12.16%912,700
BCRJoel Greenblatt 2014-09-30 Add0.27%$142.3 - $153.13
($147.81)
$ 171.4616%Add 470.83%229,325
BCRYacktman Focused Fund 2014-09-30 Reduce-0.22%$142.3 - $153.13
($147.81)
$ 171.4616%Reduce 6.52%2,150,000
BCRDonald Yacktman 2014-09-30 Reduce-0.15%$142.3 - $153.13
($147.81)
$ 171.4616%Reduce 3.85%6,443,334
BCRYacktman Fund 2014-09-30 Reduce-0.1%$142.3 - $153.13
($147.7)
$ 171.4616%Reduce 2.40%3,250,000
BCRRobert Olstein 2014-09-30 Reduce-0.08%$142.3 - $153.13
($147.7)
$ 171.4616%Reduce 10.53%34,000
BCRVanguard Health Care Fund 2014-09-30 Reduce-0.04%$142.3 - $153.13
($147.7)
$ 171.4616%Reduce 10.22%1,039,100
BCRVanguard Health Care Fund 2014-06-30 Reduce-0.28%$136.23 - $149.25
($142.86)
$ 171.4620%Reduce 37.07%1,157,400
BCRRobert Olstein 2014-06-30 Add0.15%$136.23 - $149.25
($142.86)
$ 171.4620%Add 26.67%38,000
BCRYacktman Fund 2014-06-30 Reduce-0.12%$136.23 - $149.25
($142.86)
$ 171.4620%Reduce 2.76%3,330,000
BCRDonald Yacktman 2014-06-30 Reduce-0.08%$136.23 - $149.25
($142.95)
$ 171.4620%Reduce 1.85%6,701,207
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Naughton Gail KDirector 2015-04-28Sell763$170.610.5view
Thompson Tommy GDirector 2015-04-28Sell1,200$170.430.6view
RING TIMOTHY MChairman and CEO 2015-03-23Sell7,628$170.650.47view
BRESLAWSKY MARC CDirector 2015-02-24Sell7,200$174.37-1.67view
RING TIMOTHY MChairman and CEO 2015-02-23Sell20,000$176.33-2.76view
DeFord John ASr. VP Sci Tech and Clin Afrs 2015-02-20Sell2,987$174.85-1.94view
HOLLAND CHRISTOPHER SSenior Vice President and CFO 2015-02-20Sell16,091$176.03-2.6view
WEILAND JOHN HPresident and COO 2015-02-19Sell8,413$174.99-2.02view
Luboff Sharon MGroup Vice President 2015-02-19Sell1,117$174.42-1.7view
Groetelaars John PGroup Vice President 2015-02-19Sell4,566$175.14-2.1view

Press Releases about BCR :

    Quarterly/Annual Reports about BCR:

    News about BCR:

    Articles On GuruFocus.com
    Medtronic Inc. (MDT) Dividend Stock Analysis Feb 25 2015 
    Reversing a Declining Pattern in Earnings Per Share Feb 24 2015 
    Teleflex Declares Its Quarter Four Results Feb 24 2015 
    Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Nov 19 2014 
    Weekly 52-Week Highs Highlight: LBTYK, STZ, FISV, BCR Nov 09 2014 
    Dividend Aristocrats In Focus Part 19 of 54: CR Bard Oct 15 2014 
    Medtronic Inc. (MDT) Dividend Stock Analysis Sep 12 2014 
    Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
    No More a Simple Distributor Sep 07 2014 
    Becton, Dickinson and Co. (BDX) Dividend Stock Analysis May 30 2014 

    More From Other Websites
    Top trades for the 2nd half: COST, LPL, SCHW & NVDA May 27 2015
    Bard to Present at Jefferies Healthcare Conference May 26 2015
    Bard to Present at Jefferies Healthcare Conference May 26 2015
    BARD C R INC /NJ/ Files SEC form 8-K, Other Events May 06 2015
    Bard to Present at the Bank of America Merrill Lynch Healthcare Conference May 05 2015
    Bard to Present at the Bank of America Merrill Lynch Healthcare Conference May 05 2015
    BARD C R INC /NJ/ Financials Apr 30 2015
    Boston Scientific (BSX) Earnings Report: Q1 2015 Conference Call Transcript Apr 28 2015
    BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report Apr 24 2015
    C.R. Bard (BCR) Q1 Earnings, Sales Top; Currency Woes Stay - Analyst Blog Apr 24 2015
    CR Bard (BCR) Earnings Report: Q1 2015 Conference Call Transcript Apr 24 2015
    C R Bard Inc Earnings Call scheduled for 5:00 pm ET today Apr 23 2015
    Bard Announces First Quarter Results Apr 23 2015
    C.R. Bard tops Street 1Q forecasts Apr 23 2015
    BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 23 2015
    Bard Announces First Quarter Results Apr 23 2015
    Q1 2015 C R Bard Inc Earnings Release - After Market Close Apr 23 2015
    C. R. Bard (BCR) Q1 Earnings: Lutonix DCB Holds the Key - Analyst Blog Apr 21 2015
    3 Stocks Breaking Out on Unusual Volume Apr 17 2015
    BARD C R INC /NJ/ Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Apr 17 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK